An observational study in Myopia and Orthokeratology, sponsored by Tianjin Eye Hospital. Completed at 1 site in China. Open to participants aged 8 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-09.
Sponsored by Tianjin Eye Hospital · Observational
Orthokeratology lens is an effective method for myopia control. This study analyzed the effects of treatment zone decentration on axial length elongation in adolescents with orthokeratology lens.
Orthokeratology lens is an effective method for myopia control. This study aimed to investigate the effects of treatment zone decentration on axial length elongation in adolescents with orthokeratology lens in 1 year. Other factors that may affect axial growth were also analyzed.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's enrollment of 251 is above the median of 150 across 173 observational studies indexed under Myopia.
Browse Myopia studies →Tianjin Eye Hospital is the lead sponsor of 49 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Myopia children with orthokeratology lens and complete follow-up.
Exclusion Criteria:
The change of axial length
The axial length was measured by IOL-Master 500, its expressed in mm
Time frame: The change of baseline、6 months and 12months
the decentration magnitudes of the treatment zone
The value of decentration magnitudes was obtained and calculated from a corneal topography
Time frame: up to 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tianjin Eye Hospital